Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion type Assertion NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_head.
- NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion wasGeneratedBy ECO_0000203 NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_provenance.
- NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion wasDerivedFrom befree-20140225 NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_provenance.
- NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion SIO_000772 20660371 NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_provenance.
- NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion evidence source_evidence_literature NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_provenance.
- NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_assertion description "[Our results offer preclinical validation of TR3 as a drug target for pancreatic cancer chemotherapy, based on the ability of TR3 inhibitors to block the growth of pancreatic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266573.RAtdkgM7FF7YVPeKrtt1O77CBIfQBoZXcnTWbFlzDyLXs130_provenance.